Expression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala

Brain, Behavior, and Immunity

Volumn 54, Issue , 2016, Pages 170-177

  Bachis, Alessia ^a   Forcelli, Patrick ^a   Masliah, Eliezer ^b,c   Campbell, Lee ^a   Mocchetti, Italo ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BDNF; Gp120 transgenic mice; IL 1 ; Light dark transition; Open field; Prepulse inhibition; TNF ; TPA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 120; TISSUE PLASMINOGEN ACTIVATOR;

AMYGDALA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BRAIN DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; EVOKED RESPONSE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGHT DARK CYCLE; MALE; MOLECULAR PATHOLOGY; MOTOR DYSFUNCTION; MOUSE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OPEN FIELD TEST; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; ANXIETY; BIOSYNTHESIS; BRAIN; DISEASE MODEL; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; VIROLOGY;

AMYGDALA; ANIMALS; ANXIETY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; MALE; MICE; MICE, TRANSGENIC; NEURONS; PREPULSE INHIBITION;

EID: 84957663660     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.01.020     Document Type: Article

References (67)

1. Alfonso J., Frasch A.C., Flugge G. Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus. Rev. Neurosci. 2005, 16:43-56.
2. Ances B.M., Ortega M., Vaida F., Heaps J., Paul R. Independent effects of HIV, aging, and HAART on brain volumetric measures. J. Acquir. Immune Defic. Syndr. 2012, 59:469-477.
3. Atkinson J.H., Heaton R.K., Patterson T.L., Wolfson T., Deutsch R., Brown S.J., Summers J., Sciolla A., Gutierrez R., Ellis R.J., Abramson I., Hesselink J.R., McCutchan J.A., Grant I., Group H. Two-year prospective study of major depressive disorder in HIV-infected men. J. Affect. Disord. 2008, 108:225-234.
4. Bachis A., Avdoshina V., Zecca L., Parsadanian M., Mocchetti I. Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons. J. Neurosci. 2012, 32:9477-9484.
5. Bachis, A., Boelk, A., Tessarollo, L., Mocchetti, I., submitted for publication. The neurotrophin receptor p75 mediates gp120-induced loss of synaptic spines in aging mice. Neurobiol. Aging.
6. Bachis A., Cruz M.I., Mocchetti I. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur. J. Neurosci. 2010, 32:570-578.
7. Baranes D., Lederfein D., Huang Y.Y., Chen M., Bailey C.H., Kandel E.R. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 1998, 21:813-825.
8. Becker B., Mihov Y., Scheele D., Kendrick K.M., Feinstein J.S., Matusch A., Aydin M., Reich H., Urbach H., Oros-Peusquens A.M., Shah N.J., Kunz W.S., Schlaepfer T.E., Zilles K., Maier W., Hurlemann R. Fear processing and social networking in the absence of a functional amygdala. Biol. Psychiatry 2012, 72:70-77.
9. Bickart K.C., Wright C.I., Dautoff R.J., Dickerson B.C., Barrett L.F. Amygdala volume and social network size in humans. Nat. Neurosci. 2011, 14:163-164.
10. Bing E.G., Burnam M.A., Longshore D., et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch. Gen. Psychiatry 2001, 58:721-728.
11. Canizares S., Cherner M., Ellis R.J. HIV and aging: effects on the central nervous system. Semin. Neurol. 2014, 34:27-34.
12. Carrico A.W. Elevated suicide rate among HIV-positive persons despite benefits of antiretroviral therapy: implications for a stress and coping model of suicide. Am. J. Psychiatry 2010, 167:117-119.
13. Chan P., Brew B. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr. HIV/AIDS Rep. 2014, 11:317-324.
14. Chapleau C.A., Pozzo-Miller L. Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology. Neural Plast. 2012, 2012:578057.
15. Clark U.S., Cohen R.A., Sweet L.H., Gongvatana A., Devlin K.N., Hana G.N., Westbrook M.L., Mulligan R.C., Jerskey B.A., White T.L., Navia B., Tashima K.T. Effects of HIV and early life stress on amygdala morphometry and neurocognitive function. J. Int. Neuropsychol. Soc. 2012, 18:657-668.
16. Cohen S., Janicki-Deverts D., Miller G.E. Psychological stress and disease. JAMA 2007, 298:1685-1687.
17. Forcelli P.A., West E.A., Murnen A.T., Malkova L. Ventral pallidum mediates amygdala-evoked deficits in prepulse inhibition. Behav. Neurosci. 2012, 126:290-300.
18. Gale G.D., Anagnostaras S.G., Godsil B.P., Mitchell S., Nozawa T., Sage J.R., Wiltgen B., Fanselow M.S. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J. Neurosci. 2004, 24:3810-3815.
19. George M.M., Bhangoo A. Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis. Rev. Endocr. Metab. Disord. 2013, 14:105-112.
20. Govindarajan A., Rao B.S., Nair D., Trinh M., Mawjee N., Tonegawa S., Chattarji S. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13208-13213.
21. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., Leblanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., Collier A.C., Marra C.M., Morgello S., Mindt M.R., Taylor M.J., Marcotte T.D., Atkinson J.H., Wolfson T., Gelman B.B., McArthur J.C., Simpson D.M., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I., Group C., Group H. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 2011, 17:3-16.
22. Henry B.L., Geyer M.A., Buell M.R., Perry W., Young J.W., Minassian A., Translational Methamphetamine A.R.C.G. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behav. Pharmacol. 2014, 25:12-22.
23. Horch H.W. Local effects of BDNF on dendritic growth. Rev. Neurosci. 2004, 15:117-129.
24. Hult J.R., Wrubel J., Branstrom R., Acree M., Moskowitz J.T. Disclosure and nondisclosure among people newly diagnosed with HIV: an analysis from a stress and coping perspective. AIDS Patient Care STDS 2012, 26:181-190.
25. Kaplan D.R., Miller F.D. Axon growth inhibition: signals from the p75 neurotrophin receptor. Nat. Neurosci. 2003, 6:435-436.
26. Kee M.K., Lee S.Y., Kim N.Y., Lee J.S., Kim J.M., Choi J.Y., Ku N.S., Kang M.W., Kim M.J., Woo J.H., Kim S.W., Song J.Y., Baek J.H., Choi B.Y., Kim S.S. Anxiety and depressive symptoms among patients infected with human immunodeficiency virus in South Korea. AIDS Care 2015, 27:1174-1182.
27. Kemppainen J.K., MacKain S., Reyes D. Anxiety symptoms in HIV-infected individuals. J. Assoc. Nurses AIDS Care 2013, 24:S29-39.
28. Koch M. Sensorimotor gating changes across the estrous cycle in female rats. Physiol. Behav. 1998, 64:625-628.
29. Krucker T., Toggas S.M., Mucke L., Siggins G.R. Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus. Neuroscience 1998, 83:691-700.
30. Lakshminarasimhan H., Chattarji S. Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PLoS ONE 2012, 7:e30481.
31. Lee M.H., Amin N.D., Venkatesan A., Wang T., Tyagi R., Pant H.C., Nath A. Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation. J. Neurovirol. 2013, 19:418-431.
32. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
33. Lewis-Fernandez R., Hinton D.E., Laria A.J., Patterson E.H., Hofmann S.G., Craske M.G., Stein D.J., Asnaani A., Liao B. Culture and the anxiety disorders: recommendations for DSM-V. Depress. Anxiety 2010, 27:212-229.
34. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
35. Liu T., Kong D., Shah B.P., Ye C., Koda S., Saunders A., Ding J.B., Yang Z., Sabatini B.L., Lowell B.B. Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron 2012, 73:511-522.
36. Massie M.J. Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr. 2004, 57-71.
37. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
38. Medcalf R.L., Van den Berg E., Schleuning W.D. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J. Cell Biol. 1988, 106:971-978.
39. Minassian A., Henry B.L., Woods S.P., Vaida F., Grant I., Geyer M.A., Perry W., Translational Methamphetamine A.R.C.G. Prepulse inhibition in HIV-associated neurocognitive disorders. J. Int. Neuropsychol. Soc. 2013, 19:709-717.
40. Mitra R., Jadhav S., McEwen B.S., Vyas A., Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9371-9376.
41. Mitra R., Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:5573-5578.
42. Mowla S.J., Pareek S., Farhadi H.F., Petrecca K., Fawcett J.P., Seidah N.G., Morris S.J., Sossin W.S., Murphy R.A. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 1999, 19:2069-2080.
43. Mutumba M., Resnicow K., Bauermeister J.A., Harper G.W., Musiime V., Snow R.C., Lepkowski J.M. Development of a psychosocial distress measure for Ugandan adolescents living with HIV. AIDS Behav. 2015, 19:380-392.
44. Nicole O., Docagne F., Ali C., Margaill I., Carmeliet P., MacKenzie E.T., Vivien D., Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 2001, 7:59-64.
45. Nosheny R.L., Bachis A., Acquas E., Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur. J. Neurosci. 2004, 20:2857-2864.
46. Olley B.O., Zeier M.D., Seedat S., Stein D.J. Post-traumatic stress disorder among recently diagnosed patients with HIV/AIDS in South Africa. AIDS Care 2005, 17:550-557.
47. Owe-Larsson B., Sall L., Salamon E., Allgulander C. HIV infection and psychiatric illness. Afr. J. Psychiatry (Johannesbg.) 2009, 12:115-128.
48. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., Teng K.K., Yung W.H., Hempstead B.L., Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
49. Paris J.J., Singh H.D., Ganno M.L., Jackson P., McLaughlin J.P. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl.) 2014, 231:2349-2360.
50. Park K.J., Grosso C.A., Aubert I., Kaplan D.R., Miller F.D. P75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat. Neurosci. 2010, 13:559-566.
51. Pawlak R., Magarinos A.M., Melchor J., McEwen B., Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat. Neurosci. 2003, 6:168-174.
52. Raber J., Toggas S.M., Lee S., Bloom F.E., Epstein C.J., Mucke L. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 1996, 226:362-373.
53. Riley K.E., Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol. Rev. 2015, 9:224-243.
54. Rogan M.T., Staubli U.V., LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997, 390:604-607.
55. Schafe G.E., Nader K., Blair H.T., LeDoux J.E. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci. 2001, 24:540-546.
56. Singh K.K., Park K.J., Hong E.J., Kramer B.M., Greenberg M.E., Kaplan D.R., Miller F.D. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat. Neurosci. 2008, 11:649-658.
57. Tan I., McArthur J. HIV-associated neurological disorders. CNS Drugs 2012, 26:123-134.
58. Tesfaye S.H., Bune G.T. Generalized psychological distress among HIV-infected patients enrolled in antiretroviral treatment in Dilla University Hospital, Gedeo zone, Ethiopia. Glob. Health Action 2014, 7:23882.
59. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994, 367:188-193.
60. Vago T., Clerici M., Norbiato G. Glucocorticoids and the immune system in AIDS. Baillieres Clin. Endocrinol. Metab. 1994, 8:789-802.
61. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002, 22:6810-6818.
62. Wan F.J., Swerdlow N.R. The basolateral amygdala regulates sensorimotor gating of acoustic startle in the rat. Neuroscience 1997, 76:715-724.
63. Weaver K.E., Llabre M.M., Duran R.E., Antoni M.H., Ironson G., Penedo F.J., Schneiderman N. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol. 2005, 24:385-392.
64. Woo N.H., Teng H.K., Siao C.J., Chiaruttini C., Pang P.T., Milner T.A., Hempstead B.L., Lu B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005, 8:1069-1077.
65. Wood G.E., Young L.T., Reagan L.P., Chen B., McEwen B.S. Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3973-3978.
66. Yang F., Je H.S., Ji Y., Nagappan G., Hempstead B., Lu B. Pro-BDNF-induced synaptic depression and retraction at developing neuromuscular synapses. J. Cell Biol. 2009, 185:727-741.
67. Yusim A., Franklin L., Brooke S., Ajilore O., Sapolsky R. Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J. Neurochem. 2000, 74:1000-1007.